Posts Tagged ‘presented’

Additional Data on Provectus’s PV-10 for Metastatic Melanoma Presented at Prominent Melanoma Conferences

Additional Data on Provectus’s PV-10 for Metastatic Melanoma Presented at Prominent Melanoma Conferences
KNOXVILLE, Tenn.–(BUSINESS WIRE)–Provectus Pharmaceuticals announced that data and study design features on PV-10 for metastatic melanoma were presented at two separate conferences.

Read more on Business Wire

2010 Hartford Breast Cancer Ride Presented by RE/MAX Results

Featuring short from 2010′s event, including the appearance by Ricardo Antonio Chavira (of Desperate Housewives) at Opening Ceremonies and special message from Jen (a stage 4 breast cancer survivor) on Saturday night. Produced, Directed and Donated by Jeff & Rita Nohner of Life Image, LLC (www.LifeImageLLC.com). Featuring music by Shannon Hurley and shannonsongs… is licensed under a Creative Commons “license” Attribution Noncommercial (3.0) creativecommons.org “Matter of Time – iDude Dreamy remix” by iDude ccmixter.org “Matter Of Time (Just In Time Mix)” by The_Don (feat. Shannon Hurley) ccmixter.org

US Oncology Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of …

US Oncology Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of …
US Oncology, Inc., the nation’s leading integrated oncology company, announced today that three investigators affiliated with US Oncology Research participated in studies that will be presented orally at the 52nd American Society of Hematology Annual Meeting and Exposition at the Orange County Convention Center in Orlando, Fla.

Read more on PR Newswire via Yahoo! Finance

Ph II data of perifosine + capecitabine in metastatic CRC to be presented at gastrointestinal cancer congress

Ph II data of perifosine + capecitabine in metastatic CRC to be presented at gastrointestinal cancer congress
Keryx Biopharmaceuticals, Inc. today announced that abstract O-0017, entitled “Subset Analysis of 5-FU Refractory Patients from a Randomized Ph II Study of Perifosine + Capecitabine (P-CAP) vs. Placebo + Capecitabine (CAP) in Patients with 2nd or 3rd Line Metastatic CRC” has been selected for oral presentation at the upcoming 12th World Congress on Gastrointestinal Cancer, to be held in …

Read more on News-Medical-Net

Phase II Advanced Breast Cancer Data to Be Presented at ASCO Highlight Promising Tumor Response and Progression-Free …

Phase II Advanced Breast Cancer Data to Be Presented at ASCO Highlight Promising Tumor Response and Progression-Free …
74% of Front-Line Patients Achieved Tumor Response, Median PFS of 6.9 Months; Study Supports Potential of Bavituximab and Paclitaxel/Carboplatin for Solid Tumors

Read more on Marketwire

Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presented at ASCO 2010

Data evaluating use of nab-paclitaxel for treatment of pancreatic cancer to be presented at ASCO 2010
Abraxis BioScience, Inc., a fully integrated biotechnology company, previously announced it will be presenting more than 30 studies, including new clinical data evaluating the use of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable suspension; paclitaxel protein albumin-bound particles for injectable suspension) for the treatment of pancreatic cancer at the …

Read more on News-Medical-Net

New data highlighting Pfizer’s approach to cancer drug development to be presented at ASCO meeting

New data highlighting Pfizer’s approach to cancer drug development to be presented at ASCO meeting
Pfizer Oncology will present new data highlighting the company’s focused approach to cancer drug development through the identification and validation of molecular targets. These results will be presented at the 46th Annual American Society of Clinical Oncology meeting in Chicago from June 4-8.

Read more on News-Medical-Net

12 Month Follow-Up Data for Isotope-Free Breast IORT Presented at ASBS Meeting

12 Month Follow-Up Data for Isotope-Free Breast IORT Presented at ASBS Meeting
Utilization of the FDA cleared Axxent® Electronic Brachytherapy, eBxâ¢, System to deliver intraoperative radiation therapy is growing as clinical experience demonstrates the isotope-free cancer treatment platform is a patient and physician friendly alternative.  Xoft will showcase a variety of IORT oncology applications at the 11th Annual Meeting of the American Society of Breast Surgeons here …

Read more on PR Newswire via Yahoo! Finance

Regulus Therapeutics’ metabolic disease program data presented at Diabetes Keystone Symposium

Regulus Therapeutics’ metabolic disease program data presented at Diabetes Keystone Symposium
Regulus Therapeutics Inc. today announced that new data from its metabolic disease program were presented at the “Diabetes” Keystone Symposium held April 12-17 in Whistler, British Columbia. The new pre-clinical research findings showed that therapeutic oligonucleotides targeting microRNA are able to improve insulin resistance and normalize plasma glucose in mouse models of diabetes while having …

Read more on News-Medical-Net

Celsion Announces Long-Term Follow-Up Data From Phase 1 ThermoDox(R) Trial is Presented at the University of Hong Kong …

Celsion Announces Long-Term Follow-Up Data From Phase 1 ThermoDox(R) Trial is Presented at the University of Hong Kong …
Celsion Corporation today announced that Dr. Ronnie T.P. Poon, a principal investigator of the Phase I ThermoDox® dose escalation trial, held a press conference at the University of Hong Kong to provide an update on the long-term follow-up data from patients treated at his center as well as present illustrative patient case studies.  The Phase I trial was conducted in 2006.  A presentation of …

Read more on PR Newswire via Yahoo! Finance